Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guidelineJadwiga A. Wedzicha, Jerry A. Krishnan, Marc Miravitlles et al.|European Respiratory Journal|2017Cited by 679
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya P. Bhatt, Raolat M. Abdulai, Klaus F. Rabe et al.|New England Journal of Medicine|2023Cited by 452
Benralizumab for the Prevention of COPD ExacerbationsGerard J. Criner, Ubaldo J. Martin, Paul Newbold et al.|New England Journal of Medicine|2019Cited by 329
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 InflammationSurya P. Bhatt, Lacey B. Robinson, Klaus F. Rabe et al.|New England Journal of Medicine|2024Cited by 240
An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary DiseaseBartolomé R. Celli, John W. Walsh, Marc Decramer et al.|American Journal of Respiratory and Critical Care Medicine|2015Cited by 217